Sodium ferulic

CAS No. 24276-84-4

Sodium ferulic ( Sodium ferulate )

Catalog No. M18293 CAS No. 24276-84-4

Sodium ferulate (SF), the sodium salt of ferulic acid, is a drug used in traditional Chinese medicine for treatment of cardiovascular and cerebrovascular diseases and to prevent thrombosis.

Purity : 98%

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG 41 In Stock
1G 50 In Stock

Biological Information

  • Product Name
    Sodium ferulic
  • Note
    Research use only, not for human use.
  • Brief Description
    Sodium ferulate (SF), the sodium salt of ferulic acid, is a drug used in traditional Chinese medicine for treatment of cardiovascular and cerebrovascular diseases and to prevent thrombosis.
  • Description
    Sodium ferulate (SF), the sodium salt of ferulic acid, is a drug used in traditional Chinese medicine for treatment of cardiovascular and cerebrovascular diseases and to prevent thrombosis.
  • Synonyms
    Sodium ferulate
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    Cardiovascular Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    24276-84-4
  • Formula Weight
    216.16
  • Molecular Formula
    C10H9NaO4
  • Purity
    98%
  • Solubility
    DMSO : 16.6 mg/mL 76.79 mM;
  • SMILES
    COC1=C(C=CC(=C1)C=CC(=O)[O-])O.[Na+]
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Lampiasi N, et al. The molecular events behind ferulic acid mediated modulation of IL-6 expression in LPS-activated Raw 264.7 cells. Immunobiology. 2015 Nov 10.
molnova catalog
related products
  • Desbenzyl Donepezil ...

    Used as organic synthesis and medicine intermediate.

  • X-alpha-Gal

    X-alpha-Gal is a substrate for alpha-galactosidase. It is used for differentiating alpha-galactosidase-positive strains of yeast.

  • Kuraridine

    Kuraridine is measured against cGMP PDE5 to identify potent cGMP specific phosphodiesterase type 5 inhibitory constituents.